Abstract
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous Coronary Intervention
In patients who have had percutaneous coronary intervention for acute coronary syndromes or stable angina dual antiplatelet therapy is required. If there is a history of atrial fibrillation, thrombosis or presence of a mechanical heart valve then long term anticoagulation may be necessary. However, the use of antiplatelets with anticoagulation increases the risk of bleeding. The need for anticoagulation in such patients needs to be carefully assessed by taking into account the risk of bleeding with anticoagulation and the risk of thromboembolic events without anticoagulation. If triple therapy is required then the shortest duration of treatment should be prescribed.
Author(s):
Shabnam Rashid
Abstract | Full-Text | PDF
Share this
30+ Million Readerbase
Archives of Medicine peer review process verified at publons
Abstracted/Indexed in
- Google Scholar
- Genamics JournalSeek
- China National Knowledge Infrastructure (CNKI)
- Directory of Research Journal Indexing (DRJI)
- WorldCat
- Proquest Summons
- Publons
- Geneva Foundation for Medical Education and Research
- Secret Search Engine Labs
- Euro Pub
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences